Home › Companies › KalVista Pharmaceuticals, Inc.
How asset managers voted at KalVista Pharmaceuticals, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | KalVista Pharmaceuticals, Inc. | 4 | 167 |
| 2024-2025 | KalVista Pharmaceuticals, Inc. | 4 | 140 |
| 2023-2024 | KALVISTA PHARMACEUTICALS INC. | 5 | 120 |
Earlier seasons list this company under the name KALVISTA PHARMACEUTICALS INC., as its holders filed it.
Explore KalVista Pharmaceuticals, Inc. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built October 19, 2026.